Consolidated Joint Venture - Additional Information (Detail) |
12 Months Ended | ||
---|---|---|---|
Aug. 09, 2019
Individual
|
Dec. 31, 2021
USD ($)
|
Dec. 31, 2020
USD ($)
|
|
Schedule Of Equity Method Investments [Line Items] | |||
Net loss attributable to noncontrolling interest | $ 1,474,000 | $ 1,371,000 | |
Archipelago Ventures Hawaii, LLC [Member] | Arcadia Biosciences, Inc [Member] | |||
Schedule Of Equity Method Investments [Line Items] | |||
Number of individuals appointed | Individual | 2 | ||
Joint venture interest percentage | 50.75% | ||
Capital contributions | $ 3,108,000 | ||
Archipelago Ventures Hawaii, LLC [Member] | Legacy Ventures Hawaii, LLC [Member] | |||
Schedule Of Equity Method Investments [Line Items] | |||
Number of individuals appointed | Individual | 2 | ||
Joint venture interest percentage | 49.25% | ||
Capital contributions | $ 3,016,000 |